Literature DB >> 35789301

Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography.

Li-Wei Chen1,2, Shun-Mao Yang1,3, Ching-Chia Chuang1, Hao-Jen Wang1, Yi-Chang Chen1,4, Mong-Wei Lin5, Min-Shu Hsieh6, Mara B Antonoff7, Yeun-Chung Chang4, Carol C Wu8, Tinsu Pan9, Chung-Ming Chen10.   

Abstract

BACKGROUND: High-grade adenocarcinoma subtypes (micropapillary and solid) treated with sublobar resection have an unfavorable prognosis compared with those treated with lobectomy. We investigated the potential of incorporating solid attenuation component masks with deep learning in the prediction of high-grade components to optimize surgical strategy preoperatively.
METHODS: A total of 502 patients with pathologically confirmed high-grade adenocarcinomas were retrospectively enrolled between 2016 and 2020. The SACs attention DL model was developed to apply solid-attenuation-component-like subregion masks (tumor area ≥ - 190 HU) to guide the DL model for predicting high-grade subtypes. The SACA-DL was assessed using 5-fold cross-validation and external validation in the training and testing sets, respectively. The performance, which was evaluated using the area under the curve (AUC), was compared between SACA-DL and the DL model without SACs attention (DLwoSACs), the prior radiomics model, or the model based on the consolidation/tumor (C/T) diameter ratio.
RESULTS: We classified 313 and 189 patients into training and testing cohorts, respectively. The SACA-DL achieved an AUC of 0.91 for the cross-validation, which was significantly superior to those of the DLwoSACs (AUC = 0.88; P = 0.02), prior radiomics model (AUC = 0.85; P = 0.004), and C/T ratio (AUC = 0.84; P = 0.002). An AUC of 0.93 was achieved for external validation in the SACA-DL and was significantly better than those of the DLwoSACs (AUC = 0.89; P = 0.04), prior radiomics model (AUC = 0.85; P < 0.001), and C/T ratio (AUC = 0.85; P < 0.001).
CONCLUSIONS: The combination of solid-attenuation-component-like subregion masks with the DL model is a promising approach for the preoperative prediction of high-grade adenocarcinoma subtypes.
© 2022. Society of Surgical Oncology.

Entities:  

Mesh:

Year:  2022        PMID: 35789301     DOI: 10.1245/s10434-022-12055-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   4.339


  36 in total

1.  Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma.

Authors:  So Hee Song; Hyunjin Park; Geewon Lee; Ho Yun Lee; Insuk Sohn; Hye Seung Kim; Seung Hak Lee; Ji Yun Jeong; Jhingook Kim; Kyung Soo Lee; Young Mog Shim
Journal:  J Thorac Oncol       Date:  2016-12-05       Impact factor: 15.609

2.  Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.

Authors:  Ho Yun Lee; So Won Lee; Kyung Soo Lee; Ji Yun Jeong; Joon Young Choi; O Jung Kwon; So Hee Song; Eun Young Kim; Jhingook Kim; Young Mog Shim
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

Review 3.  Is there significance in identification of non-predominant micropapillary or solid components in early-stage lung adenocarcinoma?

Authors:  Ze-Rui Zhao; Ka Fai To; Tony S K Mok; Calvin S H Ng
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-09-05

4.  Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.

Authors:  Prudence A Russell; Zoe Wainer; Gavin M Wright; Marissa Daniels; Matthew Conron; Richard A Williams
Journal:  J Thorac Oncol       Date:  2011-09       Impact factor: 15.609

Review 5.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

6.  Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.

Authors:  Akihiko Yoshizawa; Noriko Motoi; Gregory J Riely; Cami S Sima; William L Gerald; Mark G Kris; Bernard J Park; Valerie W Rusch; William D Travis
Journal:  Mod Pathol       Date:  2011-01-21       Impact factor: 7.842

7.  Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Authors:  Ming-Sound Tsao; Sophie Marguet; Gwénaël Le Teuff; Sylvie Lantuejoul; Frances A Shepherd; Lesley Seymour; Robert Kratzke; Stephen L Graziano; Helmut H Popper; Rafael Rosell; Jean-Yves Douillard; Thierry Le-Chevalier; Jean-Pierre Pignon; Jean-Charles Soria; Elisabeth M Brambilla
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

8.  New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.

Authors:  Naoki Yanagawa; Satoshi Shiono; Masami Abiko; Shin-ya Ogata; Toru Sato; Gen Tamura
Journal:  J Thorac Oncol       Date:  2013-05       Impact factor: 15.609

9.  Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.

Authors:  Ze-Rui Zhao; Shao-Yan Xi; Wei Li; Dong-Rong Situ; Ke-Ming Chen; Han Yang; Xiao-Dong Su; Yong-Bin Lin; Hao Long
Journal:  Lung Cancer       Date:  2015-11-04       Impact factor: 5.705

10.  Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.

Authors:  Jie Zhang; Jie Wu; Qiang Tan; Lei Zhu; Wen Gao
Journal:  J Thorac Oncol       Date:  2013-09       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.